Clinical Trial Update: Durvalumab Plus Etoposide-free Chemotherapy in First-line Treatment of Extensive-disease Small-sell Lung Cancer (SCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating durvalumab with etoposide-free chemotherapy as first-line treatment for extensive-stage small cell lung cancer; currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Durvalumab (Imfinzi) (durvalumab)

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Small Cell Lung Cancer Extensive Stage | Phase 2 | Status: ACTIVE_NOT_RECRUITING